PRESS RELEASE published on 01/19/2026 at 10:00, 9 months 23 days ago Medios AG enters market for medicinal cannabis Medios AG expands into medicinal cannabis market with exclusive distribution rights for Bedrocan products in Europe, strengthening expertise in oncology and neurology Pharmaceuticals Oncology Medios AG Medicinal Cannabis Bedrocan
BRIEF published on 11/11/2025 at 07:29, 1 year ago Medios AG annonce une forte croissance de ses bénéfices début 2025 EBITDA Performance Financière Medios AG Croissance Des Revenus Médicaments
BRIEF published on 11/11/2025 at 07:29, 1 year ago Medios AG Reports Robust Earnings Growth in Early 2025 EBITDA Revenue Growth Financial Performance Pharmaceuticals Medios AG
PRESS RELEASE published on 11/11/2025 at 07:24, 1 year ago Medios AG achieves strong growth in earnings and profit margin in the first nine months of 2025 Medios AG achieves 9.2% revenue growth and 26.1% increase in EBITDA pre1 in the first nine months of 2025. New CEO appointed. Outlook confirmed. Details in press release EBITDA Revenue Growth CEO Appointment Medios AG 2025 Outlook
BRIEF published on 11/03/2025 at 10:02, 1 year ago Thomas Meier Appointed CEO of Medios AG Growth Strategy CEO Appointment Medios AG Specialty Pharma Thomas Meier
BRIEF published on 11/03/2025 at 10:02, 1 year ago Thomas Meier nommé PDG de Medios AG Stratégie De Croissance Medios AG Nomination Du PDG Pharmacie Spécialisée Thomas Meier
PRESS RELEASE published on 11/03/2025 at 09:57, 1 year ago Thomas Meier becomes new CEO of Medios AG Thomas Meier appointed as new CEO of Medios AG effective February 1, 2026, succeeding Matthias Gaertner. Meier's past roles include CEO of Bachem Holding AG. Medios AG aims for further growth under his leadership CEO Appointment Medios AG Specialty Pharma Thomas Meier Bachem Holding AG
BRIEF published on 10/24/2025 at 11:09, 1 year ago Medios AG: Reallocation of Bencis Shares Medios AG Specialty Pharma Share Reallocation Bencis Capital Partners Janus Henderson Group
BRIEF published on 10/24/2025 at 11:09, 1 year ago Medios AG : Réattribution des actions Bencis Medios AG Pharmaceutique Spécialisée Réallocation Des Actions Bencis Capital Partners Groupe Janus Henderson
PRESS RELEASE published on 10/24/2025 at 11:04, 1 year ago Medios AG: Reallocation of Bencis shares Medios AG announces reallocation of Bencis shares to Janus Henderson, representing approximately 6.7% of share capital. Bencis sold shares acquired in 2024 through capital increase related to Ceban Pharmaceuticals B.V Janus Henderson Medios AG Specialty Pharma Bencis Shares Individualized Medicine
Published on 11/12/2026 at 01:40, 6 hours 10 minutes ago Nexteer Announces First Share Repurchase Programme of Up to US$60 Million
Published on 11/11/2026 at 23:30, 8 hours 20 minutes ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 8 hours 45 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 8 hours 50 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 9 hours 20 minutes ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/12/2026 at 07:45, 5 minutes ago Eckert & Ziegler: Adjusted EBIT +25% in the Third Quarter. 2026 Forecast Confirmed
Published on 11/12/2026 at 07:45, 5 minutes ago Aumann maintains high profitability, further expands growth in Next Automation and refines its guidance for the 2026 financial year
Published on 11/12/2026 at 07:45, 5 minutes ago Fresenius completes sale of 13.4 million Fresenius Medical Care shares at €39.00 per share, raising approximately €524 million
Published on 11/12/2026 at 07:35, 15 minutes ago Desay SV Opens Smart Manufacturing Facility in Linares, Spain, Strengthening Its European Presence
Published on 11/12/2026 at 07:33, 16 minutes ago 9M 2026: MLP increases revenue and earnings significantly to new record highs
Published on 11/10/2026 at 18:00, 1 day 13 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 14 hours ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 1 day 14 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 14 hours ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
